Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial (Q38385410)
Jump to navigation
Jump to search
scientific article published on 13 July 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial |
scientific article published on 13 July 2015 |
Statements
1 reference
Analysis of circulating DNA and protein biomarkers to predict the clinical activity of regorafenib and assess prognosis in patients with metastatic colorectal cancer: a retrospective, exploratory analysis of the CORRECT trial (English)
1 reference
Alberto Sobrero
Yves Humblet
Olivier Bouché
Laurent Mineur
Carlo Barone
Antoine Adenis
Richard M Goldberg
Daniel J Sargent
Andrea Wagner
Dirk Laurent
Michael Teufel
Michael Jeffers
Axel Grothey
Eric Van Cutsem
Heinz-Josef Lenz
13 July 2015
1 reference
1 reference
1 reference